Selected research
Industry Growth & Trends
Global Propofol Drug Industry Growth and Trends Forecast to 2032
Market perspective
The global Propofol Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Propofol Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Propofol Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Propofol Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Propofol Drug include Xi’an Libang Pharmaceutical, Sichuan Kelun Pharmaceutical, Jiangsu Yingke Biopharmaceutical, Guangdong Jiabo Pharmaceutical, Jiangsu Nhwa Pharmaceutical, Beijing Sciecure Pharmaceutical, Sichuan Biokin Pharmaceutical, Wellona Pharma and Rusoma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Propofol Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Propofol Drug market size, estimates, and forecasts are presented in terms of sales volume (M Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Propofol Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Propofol Drug.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Propofol Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Propofol Drug Market by Company
Xi’an Libang Pharmaceutical
Sichuan Kelun Pharmaceutical
Jiangsu Yingke Biopharmaceutical
Guangdong Jiabo Pharmaceutical
Jiangsu Nhwa Pharmaceutical
Beijing Sciecure Pharmaceutical
Sichuan Biokin Pharmaceutical
Wellona Pharma
Rusoma
Pfizer
NEON
Fresenius Kabi
Flagship Biotech
Dr. Reddy's Laboratories
Centurion Healthcare
B. Braun
Aspen Pharma
Propofol Drug Segment by Type
50 mL
20 mL
100 mL
10 mL
Propofol Drug Segment by Application
Mechanical Ventilation
General Anesthesia
Medical Procedures Sedation
Other
Propofol Drug Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Propofol Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Propofol Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Propofol Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Propofol Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Propofol Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 50 mL
- 20 mL
- 100 mL
- 10 mL
Applications
- Mechanical Ventilation
- General Anesthesia
- Medical Procedures Sedation
- Other
Companies covered
- Xi’an Libang Pharmaceutical
- Sichuan Kelun Pharmaceutical
- Jiangsu Yingke Biopharmaceutical
- Guangdong Jiabo Pharmaceutical
- Jiangsu Nhwa Pharmaceutical
- Beijing Sciecure Pharmaceutical
- Sichuan Biokin Pharmaceutical
- Wellona Pharma
- Rusoma
- Pfizer
- NEON
- Fresenius Kabi
- Flagship Biotech
- Dr. Reddy's Laboratories
- Centurion Healthcare
- B. Braun
- Aspen Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Propofol Drug Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Propofol Drug Sales Estimates and Forecasts (2021-2032)
- 1.3 Propofol Drug Market by Type
- 1.3.1 50 mL
- 1.3.2 20 mL
- 1.3.3 100 mL
- 1.3.4 10 mL
- 1.4 Global Propofol Drug Market Size by Type
- 1.4.1 Global Propofol Drug Market Size Overview by Type (2021-2032)
- 1.4.2 Global Propofol Drug Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Propofol Drug Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Propofol Drug Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Propofol Drug Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Propofol Drug Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Propofol Drug Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Propofol Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Propofol Drug Industry Trends
- 2.2 Propofol Drug Industry Drivers
- 2.3 Propofol Drug Industry Opportunities and Challenges
- 2.4 Propofol Drug Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Propofol Drug Revenue (2021-2026)
- 3.2 Global Top Players by Propofol Drug Sales (2021-2026)
- 3.3 Global Top Players by Propofol Drug Price (2021-2026)
- 3.4 Global Propofol Drug Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Propofol Drug Major Company Production Sites & Headquarters
- 3.6 Global Propofol Drug Company, Product Type & Application
- 3.7 Global Propofol Drug Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Propofol Drug Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Propofol Drug Players Market Share by Revenue in 2025
- 3.8.3 2025 Propofol Drug Tier 1, Tier 2, and Tier 3
4 Propofol Drug Regional Status and Outlook
- 4.1 Global Propofol Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Propofol Drug Historic Market Size by Region
- 4.2.1 Global Propofol Drug Sales in Volume by Region (2021-2026)
- 4.2.2 Global Propofol Drug Sales in Value by Region (2021-2026)
- 4.2.3 Global Propofol Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Propofol Drug Forecasted Market Size by Region
- 4.3.1 Global Propofol Drug Sales in Volume by Region (2027-2032)
- 4.3.2 Global Propofol Drug Sales in Value by Region (2027-2032)
- 4.3.3 Global Propofol Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Propofol Drug by Application
- 5.1 Propofol Drug Market by Application
- 5.1.1 Mechanical Ventilation
- 5.1.2 General Anesthesia
- 5.1.3 Medical Procedures Sedation
- 5.1.4 Other
- 5.2 Global Propofol Drug Market Size by Application
- 5.2.1 Global Propofol Drug Market Size Overview by Application (2021-2032)
- 5.2.2 Global Propofol Drug Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Propofol Drug Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Propofol Drug Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Propofol Drug Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Propofol Drug Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Propofol Drug Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Propofol Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Xi’an Libang Pharmaceutical
- 6.1.1 Xi’an Libang Pharmaceutical Company Information
- 6.1.2 Xi’an Libang Pharmaceutical Business Overview
- 6.1.3 Xi’an Libang Pharmaceutical Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Xi’an Libang Pharmaceutical Propofol Drug Product Portfolio
- 6.1.5 Xi’an Libang Pharmaceutical Recent Developments
- 6.2 Sichuan Kelun Pharmaceutical
- 6.2.1 Sichuan Kelun Pharmaceutical Company Information
- 6.2.2 Sichuan Kelun Pharmaceutical Business Overview
- 6.2.3 Sichuan Kelun Pharmaceutical Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Sichuan Kelun Pharmaceutical Propofol Drug Product Portfolio
- 6.2.5 Sichuan Kelun Pharmaceutical Recent Developments
- 6.3 Jiangsu Yingke Biopharmaceutical
- 6.3.1 Jiangsu Yingke Biopharmaceutical Company Information
- 6.3.2 Jiangsu Yingke Biopharmaceutical Business Overview
- 6.3.3 Jiangsu Yingke Biopharmaceutical Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Jiangsu Yingke Biopharmaceutical Propofol Drug Product Portfolio
- 6.3.5 Jiangsu Yingke Biopharmaceutical Recent Developments
- 6.4 Guangdong Jiabo Pharmaceutical
- 6.4.1 Guangdong Jiabo Pharmaceutical Company Information
- 6.4.2 Guangdong Jiabo Pharmaceutical Business Overview
- 6.4.3 Guangdong Jiabo Pharmaceutical Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Guangdong Jiabo Pharmaceutical Propofol Drug Product Portfolio
- 6.4.5 Guangdong Jiabo Pharmaceutical Recent Developments
- 6.5 Jiangsu Nhwa Pharmaceutical
- 6.5.1 Jiangsu Nhwa Pharmaceutical Company Information
- 6.5.2 Jiangsu Nhwa Pharmaceutical Business Overview
- 6.5.3 Jiangsu Nhwa Pharmaceutical Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Jiangsu Nhwa Pharmaceutical Propofol Drug Product Portfolio
- 6.5.5 Jiangsu Nhwa Pharmaceutical Recent Developments
- 6.6 Beijing Sciecure Pharmaceutical
- 6.6.1 Beijing Sciecure Pharmaceutical Company Information
- 6.6.2 Beijing Sciecure Pharmaceutical Business Overview
- 6.6.3 Beijing Sciecure Pharmaceutical Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Beijing Sciecure Pharmaceutical Propofol Drug Product Portfolio
- 6.6.5 Beijing Sciecure Pharmaceutical Recent Developments
- 6.7 Sichuan Biokin Pharmaceutical
- 6.7.1 Sichuan Biokin Pharmaceutical Company Information
- 6.7.2 Sichuan Biokin Pharmaceutical Business Overview
- 6.7.3 Sichuan Biokin Pharmaceutical Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Sichuan Biokin Pharmaceutical Propofol Drug Product Portfolio
- 6.7.5 Sichuan Biokin Pharmaceutical Recent Developments
- 6.8 Wellona Pharma
- 6.8.1 Wellona Pharma Company Information
- 6.8.2 Wellona Pharma Business Overview
- 6.8.3 Wellona Pharma Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Wellona Pharma Propofol Drug Product Portfolio
- 6.8.5 Wellona Pharma Recent Developments
- 6.9 Rusoma
- 6.9.1 Rusoma Company Information
- 6.9.2 Rusoma Business Overview
- 6.9.3 Rusoma Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Rusoma Propofol Drug Product Portfolio
- 6.9.5 Rusoma Recent Developments
- 6.10 Pfizer
- 6.10.1 Pfizer Company Information
- 6.10.2 Pfizer Business Overview
- 6.10.3 Pfizer Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Pfizer Propofol Drug Product Portfolio
- 6.10.5 Pfizer Recent Developments
- 6.11 NEON
- 6.11.1 NEON Company Information
- 6.11.2 NEON Business Overview
- 6.11.3 NEON Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 NEON Propofol Drug Product Portfolio
- 6.11.5 NEON Recent Developments
- 6.12 Fresenius Kabi
- 6.12.1 Fresenius Kabi Company Information
- 6.12.2 Fresenius Kabi Business Overview
- 6.12.3 Fresenius Kabi Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Fresenius Kabi Propofol Drug Product Portfolio
- 6.12.5 Fresenius Kabi Recent Developments
- 6.13 Flagship Biotech
- 6.13.1 Flagship Biotech Company Information
- 6.13.2 Flagship Biotech Business Overview
- 6.13.3 Flagship Biotech Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Flagship Biotech Propofol Drug Product Portfolio
- 6.13.5 Flagship Biotech Recent Developments
- 6.14 Dr. Reddy's Laboratories
- 6.14.1 Dr. Reddy's Laboratories Company Information
- 6.14.2 Dr. Reddy's Laboratories Business Overview
- 6.14.3 Dr. Reddy's Laboratories Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Dr. Reddy's Laboratories Propofol Drug Product Portfolio
- 6.14.5 Dr. Reddy's Laboratories Recent Developments
- 6.15 Centurion Healthcare
- 6.15.1 Centurion Healthcare Company Information
- 6.15.2 Centurion Healthcare Business Overview
- 6.15.3 Centurion Healthcare Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Centurion Healthcare Propofol Drug Product Portfolio
- 6.15.5 Centurion Healthcare Recent Developments
- 6.16 B. Braun
- 6.16.1 B. Braun Company Information
- 6.16.2 B. Braun Business Overview
- 6.16.3 B. Braun Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 B. Braun Propofol Drug Product Portfolio
- 6.16.5 B. Braun Recent Developments
- 6.17 Aspen Pharma
- 6.17.1 Aspen Pharma Company Information
- 6.17.2 Aspen Pharma Business Overview
- 6.17.3 Aspen Pharma Propofol Drug Sales, Revenue and Gross Margin (2021-2026)
- 6.17.4 Aspen Pharma Propofol Drug Product Portfolio
- 6.17.5 Aspen Pharma Recent Developments
7 North America by Country
- 7.1 North America Propofol Drug Sales by Country
- 7.1.1 North America Propofol Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Propofol Drug Sales by Country (2021-2026)
- 7.1.3 North America Propofol Drug Sales Forecast by Country (2027-2032)
- 7.2 North America Propofol Drug Market Size by Country
- 7.2.1 North America Propofol Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Propofol Drug Market Size by Country (2021-2026)
- 7.2.3 North America Propofol Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Propofol Drug Sales by Country
- 8.1.1 Europe Propofol Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Propofol Drug Sales by Country (2021-2026)
- 8.1.3 Europe Propofol Drug Sales Forecast by Country (2027-2032)
- 8.2 Europe Propofol Drug Market Size by Country
- 8.2.1 Europe Propofol Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Propofol Drug Market Size by Country (2021-2026)
- 8.2.3 Europe Propofol Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Propofol Drug Sales by Country
- 9.1.1 Asia-Pacific Propofol Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Propofol Drug Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Propofol Drug Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Propofol Drug Market Size by Country
- 9.2.1 Asia-Pacific Propofol Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Propofol Drug Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Propofol Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Propofol Drug Sales by Country
- 10.1.1 South America Propofol Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Propofol Drug Sales by Country (2021-2026)
- 10.1.3 South America Propofol Drug Sales Forecast by Country (2027-2032)
- 10.2 South America Propofol Drug Market Size by Country
- 10.2.1 South America Propofol Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Propofol Drug Market Size by Country (2021-2026)
- 10.2.3 South America Propofol Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Propofol Drug Sales by Country
- 11.1.1 Middle East and Africa Propofol Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Propofol Drug Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Propofol Drug Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Propofol Drug Market Size by Country
- 11.2.1 Middle East and Africa Propofol Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Propofol Drug Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Propofol Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Propofol Drug Value Chain Analysis
- 12.1.1 Propofol Drug Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Propofol Drug Production Mode & Process
- 12.2 Propofol Drug Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Propofol Drug Distributors
- 12.2.3 Propofol Drug Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst